Cargando…
YD277 Suppresses Triple-Negative Breast Cancer Partially Through Activating the Endoplasmic Reticulum Stress Pathway
Triple-negative breast cancer (TNBC) is an aggressive malignancy with poor clinical outcomes. YD277 is a novel small molecule derived from ML264, a KLF5 inhibitor that elicits cytotoxic effects in colon cancer cell lines. Our previous studies suggest that Krüpple-like factor 5 (KLF5) is a promising...
Autores principales: | Chen, Zekun, Wu, Qiuju, Ding, Ye, Zhou, Wenhui, Liu, Rong, Chen, Haiying, Zhou, Jia, Feng, Jing, Chen, Ceshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505065/ https://www.ncbi.nlm.nih.gov/pubmed/28740556 http://dx.doi.org/10.7150/thno.17555 |
Ejemplares similares
-
Isochromanoindolenines suppress triple-negative breast cancer cell proliferation partially via inhibiting Akt activation
por: Jiang, Xiaoyan, et al.
Publicado: (2021) -
Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2
por: Zhou, Wenhui, et al.
Publicado: (2019) -
miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5
por: Zhou, Wenhui, et al.
Publicado: (2017) -
Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1
por: Liu, Rong, et al.
Publicado: (2018) -
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)